EFM
CGEM icon

E Fund Management’s Cullinan Oncology CGEM Stock Holding History

E Fund Management’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-74,843
Closed -$912K – 402
2024
Q4 		$912K Sell
74,843
-996
-1% -$14.3K 0.05% 156
2024
Q3 		$1.27M Buy
75,839
+1,012
+1% +$18K 0.07% 122
2024
Q2 		$1.3M Buy
+74,827
New +$1.59M 0.07% 105

Other funds holding CGEM

MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

E Fund Management's CGEM Position: Q1 2025 in Review

E Fund Management sold out of Cullinan Oncology (CGEM) in Q1 2025, closing a stake of 74,843 shares — an estimated $912K sold.

E Fund Management first reported a position in CGEM in Q2 2024 and held it in 3 quarters. The position peaked at $1.3M in Q2 2024. 148 funds tracked by Wall St. Rank hold CGEM as of Q1 2025.

  • E Fund Management reported no remaining Cullinan Oncology position as of Q1 2025 after selling out during the quarter.
  • E Fund Management sold 74,843 Cullinan Oncology shares in Q1 2025, an estimated $912K.
  • E Fund Management first reported a position in Cullinan Oncology in Q2 2024 and held it in 3 quarters.
  • E Fund Management's Cullinan Oncology position peaked at $1.3M in Q2 2024.
  • 148 funds tracked by Wall St. Rank held Cullinan Oncology as of Q1 2025.

Based on E Fund Management's 13F filing for Q1 2025, filed 13 May 2025.